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Abstract
Akt1, a serine-threonine protein kinase member of the PKB/Akt gene family, plays critical roles in the regulation of multiple
cellular processes, and has previously been implicated in lactation and breast cancer development. In this study, we utilized
Akt1+/+ and Akt12/2 C57/Bl6 female mice to assess the role that Akt1 plays in normal mammary gland postnatal
development and function. We examined postnatal morphology at multiple time points, and analyzed gene and protein
expression changes that persist into adulthood. Akt1 deficiency resulted in several mammary gland developmental defects,
including ductal outgrowth and defective terminal end bud formation. Adult Akt12/2 mammary gland composition
remained altered, exhibiting fewer alveolar buds coupled with increased epithelial cell apoptosis. Microarray analysis
revealed that Akt1 deficiency altered expression of genes involved in numerous biological processes in the mammary gland,
including organismal development, cell death, and tissue morphology. Of particular importance, a significant decrease in
expression of Btn1a1, a gene involved in milk lipid secretion, was observed in Akt12/2 mammary glands. Additionally,
pseudopregnant Akt12/2 females failed to induce Btn1a1 expression in response to hormonal stimulation compared to
their wild-type counterparts. Retroviral-mediated shRNA knockdown of Akt1 and Btn1a1 in MCF-7 human breast epithelial
further illustrated the importance of Akt1 in mammary epithelial cell proliferation, as well as in the regulation of Btn1a1 and
subsequent expression of ß-casein, a gene that encodes for milk protein. Overall these findings provide mechanistic insight
into the role of Akt1 in mammary morphogenesis and function.
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Introduction
The mammary gland is a complex structure composed of
epithelium surrounded by stroma. Mammary gland postnatal
development is an intricate process controlled by steroid and
peptide hormones in specific stages that is highly conserved in
mammals. Unlike many other organs which undergo development
in utero, mammary gland development and ductal branching occurs
during puberty [1]. While mice have five pairs of mammary glands
compared to one pair in humans, mammary gland development
remains similar between the two species, making the mouse a good
model to study mammary gland development. During embryonic
development in the mouse, a rudimentary ductal structure invades
the mesenchyma, and remains dormant until approximately
21 days of age, when the onset of ovarian hormone secretion
stimulates ductal growth [2].
During puberty, the ovarian hormones estradiol and progester-
one stimulate stem cell proliferation in terminal end buds (TEBs)
and induce side branching in the mammary gland, respectively
[3]. The TEB is found exclusively in the developing mammary
gland, and is the main driving force for mammary gland develop-
ment [4,5]. The outer layer, or cap layer, of the TEB contains a
special population of pluripotent stem cells [2], which ultimately
differentiate to form the intermediate, luminal, and myoepithelial
cells of the duct [6]. TEB formation and side branching drive
mammary gland invasion into the fat pad until the fat pad is filled
at approximately 10 weeks of age. Once the ducts have filled the
entire mammary fat pad, TEBs are permanently replaced by
terminal ducts and alveolar buds [7]. It has been proposed that the
adult mammary gland retains a mammary stem cell population
which gives rise to epithelial precursor cells [6]. The progeny of
the epithelial precursor cells are either ductal precursor cells or
alveolar precursor cells. The presence of these stem cells is thought
to underlie the ability of the mammary gland to undergo alveolar
renewal with subsequent pregnancies [3]. It has also been shown
that the mammary epithelium is the major target for carcinogen-
induced initiation during tumorigenesis, making the understanding
of the mechanisms underlying mammary gland development and
function imperative for knowledge of reproductive function and
for designing effective anticancer therapies [8].
Protein kinase B/Akt is a serine/threonine kinase that plays a
central role in regulation of cell metabolism, cell survival, motility,
transcription, and cell-cycle progression [9,10]. The Akt gene
family is activated in a phosphoinositide 3 kinase- dependent
manner by a variety of signals including cytokines, growth factors,
and hormones. The Akt family includes three isoforms, Akt1, Akt2,
and Akt3, which share 80% amino acid homology but have distinct
roles in regulating cellular activity [9]. Akt1 is the predominant
isoform, and plays a role in placental development, organismal
growth, adipogenesis, mammary gland lactation and involution,
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ablation has been shown to delay mammary gland growth during
pregnancy and lactation, and accelerates the rate of involution
following lactation [11,14]. Conversely, constitutively active Akt1
delays epithelial cell apoptosis and mammary gland involution [18].
Of note, Akt1-deficient dams produce less milk during nursing, and
consequently have smaller pup weights regardless of the pup
genotype [11,19]. It has been previously shown that Akt1 ablation
delays the onset of puberty and results in subfertility in C57/Bl6
mice [20]. Akt1 deficiency also increases the levels of the hormone
estradiol and decreases the levels of progesterone at postnatal day
50; however, hormone levels in wild-type and Akt1-deficient mice
are comparable by postnatal day 90 [20]. Interestingly, estradiol
and progesterone are responsible for ductal growth and alveolar
expansion in mammary glands, respectively [3]. These previous
studies led us to examine the molecular mechanisms underlying the
requirement for Akt1 in mammary gland development and function.
Although Akt1 is implicated in lactation and involution as well as
mammary carcinogenesis, its functional roles in regulating mam-
mary gland development and influencing adult mammary gland
structure are not yet fully understood. In this study, we show that
Akt1 is essential for proper mammary gland composition during
development and for appropriate gene expression patterns in
adulthood. We found that Akt1 deficiency delayed mammary
gland development, with fewer TEBs during puberty and fewer
and smaller alveolar buds in adulthood, potentially due to in-
creased apoptosis in the epithelial compartment. Our data further
indicate that Akt1 deficiency resulted in gene expression changes
and several altered biological processes, which could affect cellular
composition and function, leading to impaired lactation. Specif-
ically, in both adult virgin Akt12/2 mammary glands and
pseudopregnant Akt12/2 glands we found down-regulation of
Btn1a1, which has previously been shown to be critical for milk
lipid secretion [21]. We also show that suppression of Akt1 in
MCF7 human breast epithelial cells decreases expression of
Btn1a1, indicating a role for Akt1 in the regulation of Btn1a1.
Suppression of Btn1a1 decreased expression of Btn1a1 but not Akt1,
suggesting that Btn1a1 functions downstream of Akt1. Taken
together, our results indicate that Akt1 regulates mammary gland
postnatal development as well as lobuloalveolar development
through the regulation of apoptosis and gene expression.
Materials and Methods
Ethics Statement
The Brown University Institutional Animal Care and Use
Committee (IACUC) approved all experimental animal protocols
in compliance with National Institute of Health guidelines. The
IACUC approval number is 0909078 and date of approval was 10/
7/2010.
Animals
Akt1 heterozygous mice (Mus musculus) on a C57/BL6
background were obtained from the laboratory of Dr. Morris
Birnbaum (University of Pennsylvania, Philadelphia, PA). Hetero-
zygous pairs were mated to obtain Akt1 +/+ and Akt1 2/2
females for experimental procedures. Animals were housed in
polycarbonate cages and were given access to water and feed ad
libidum. Animals were sacrificed by CO2 asphyxiation at PND
(postnatal day) 11, PND 25, PND 50 or PND 70.
Mammary gland whole mounts
Inguinal mammary glands from the fourth and ninth positions
were removed, fixed in Carnoy’s solution for 2–4 hours, stained
overnight in carmine solution, rinsed in alcohol and cleared in
xylene overnight. Whole mounts were examined and images were
taken using a Zeiss Discovery V8 stereomicroscope equipped with
an Axiocam MRc camera and Axiovert Software (Carl Zeiss
Canada Ltd., Canada). The criterion for scoring varied depending
upon the age of the mouse group being evaluated. The primary
duct length was measured at PND 11 and PND 25 using the curve
spline measurement feature. Since the mammary glands are
significantly larger at PND 50 and 70, the length of growth past
the lymph node was measured instead of the primary duct length
by using the length measurement feature. Ductal outgrowth was
measured using the outline spline measurement feature as the area
occupied by the entire mammary gland for all time points.
Terminal end buds and alveolar buds were measured for all time
points in the Zone C area of the mammary gland, which for this
study is defined as the area comprised of the outer 1 mm of the
entire mammary gland [22]. Terminal end buds were defined as
having a diameter of $100 mm. The number of total buds was
comprised of terminal end buds ($100 mm) and alveolar buds
(,100 mm). The percentage of terminal end buds was calculated
by dividing the number of terminal end buds by the number of
total buds. The scores from the fourth and ninth position
mammary glands from each animal were averaged and the mean
was used to represent that animal.
Histological analysis
Mammary gland whole mounts were manually embedded in
paraffin and cut into 7-mm sections for histological analysis. Fol-
lowing deparaffinization, mammary gland sections were washed in
0.1% lithium carbonate to remove carmine aluminum stain. Mam-
mary sections were stained with hematoxylin and eosin (H&E) and
martius yellow, soluble blue,brilliantcrystal (MSB)stain forfibrinto
examinebasicpathology.Alveolarbuddiametersweremeasuredon
the Aperio ImageScope v10.2 (Aperio Technologies Vista, CA). At
least 20 measurements per animal were taken and the mean was
used to represent that animal.
Western blots
Thoracic mammary glands were pulverized in liquid nitrogen
then lysed in cold RIPA buffer (20 mM Tris 8.0, 150 mM NaCl,
0.5% sodium deoxyocholate, 0.1% SDS, 1% NP-40, 10 mM
sodium pyrophosphate, 10 mM sodium fluoride) supplemented
with 60 ml/ml HALT protease/phosphatase inhibitors (Thermo
Scientific, Waltham, MA) and 1 mM PMSF (Roche, Indianapolis,
IN). Lysates were incubated on ice for 20 minutes with frequent
vortexing and cleared twice by centrifugation (13,200 rpm,
10 minutes, 4uC). MCF7 cells were lysed in cold lysis buffer
(50 mM Tris pH 8.0, 250 mM NaCl, 1% NP-40, 0.1% SDS,
5 mM EDTA, 2 mM sodium orthovanadate, 10 mM sodium
pyrophosphate, 10 mM sodium fluoride), incubated on ice for
20 minutes and cleared by centrifugation (13,200 rpm, 10 min-
utes, 4uC). Protein concentrations were determined using the DC
Protein Assay (Bio-Rad). Fifty micrograms of total protein was
subjected to SDS-PAGE and transferred onto Immobilon-P PVDF
(Millipore, Billerica, MA). Membranes were blocked for 60 min-
utes at room temperature in 5% non-fat milk/Tris-buffered
saline/0.1% Tween (TBST). Membranes were incubated for
2 hours at room temperature then overnight at 4uC in one the
following antibodies: AKT1 (#2938, 1:1000 in 5% BSA/TBST),
AKT2 (#2964, 1:1000 in 5% BSA/TBST), AKT3 (#3788,
1:1000 in 5% BSA/TBST), or GAPDH (AM4300, 1:4000,
Applied Biosystems). All antibodies were obtained from Cell
Signaling Technology (Danvers, MA) unless indicated otherwise.
Membranes were washed 3 times (5 minutes per wash) in TBST,
Akt1 in Mammary Development
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peroxidase conjugated goat anti-rabbit IgG (1:2000, Cell Signal-
ing) or goat anti-mouse IgG (1:10,000 Millipore) diluted in 5%
milk/TBST. Membranes were washed 3 times (5 minutes per
wash) in TBST and once in TBS prior to visualization using
enhanced chemiluminescence (Thermo Scientific).
Determination of apoptotic rates by terminal
deoxynucleotidyl transferase mediated dUTP nick end
labeling (TUNEL) staining and quantitation
PND 70 mammary glands were stained for apoptosis using the
ApopTag kit (Chemicon, Temecula, CA) according to the manu-
facturer’s instructions. Tissues were counterstained with hematox-
ylin. Digital images were captured using the Aperio Scanscope
Imagine System (Aperio Technologies, Vista, CA), and TUNEL
positive nuclei were measured using the nuclear algorithm analysis
on the Aperio Imagescope v10.2. At least 200 cells per animal were
measured.
RNA isolation
RNA was isolated from thoracic mammary glands from mice
(PND70) previously flash frozen in liquid nitrogen or MCF7
cells using the mirVANA RNA Isolation Kit (Ambion Inc.,
Austin, TX) according to manufacturer’s protocols. RNA con-
centration was quantified using a ND-1000 spectrophotometer
(Nanodrop, Wilmington, DE), aliquoted, and stored at 280uC
until needed.
RNA microarray hybridization
Integrity of RNA isolated from thoracic mammary glands
was assessed using an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, Palo Alto, CA). Complementary DNA (cDNA) was
synthesized from 300 ng of total RNA and purified according to
the manufacturer’s protocol (Affymetrix, Santa Clara, CA.).
Equal amounts of purified cDNA were used as the template for
subsequent in vitro transcription reactions for complementary
RNA (cRNA) amplification and biotin labeling using the
Affymetrix RNA Transcript Labeling Kit. cRNA was purified
and fragmented according to the protocol provided with the
GeneChip Sample Cleanup Module (Affymetrix, Santa Clara,
CA). All GeneChip microarrays (Mouse Genome 430 2.0 Array)
were hybridized, washed, stained, and scanned using the Com-
plete Gene Chip Instrument System according to the Affymetrix
Technical Manual. The Mouse Genome 430 2.0 microarray
contained 17 probe sets.
Microarray data analysis
All data is MIAME compliant and data is publically available
at GEO with accession number: GSE30671. Affymetrix CEL files
were imported into PartekH Genomics Suite
TM 6.5 (Partek Inc.,
St. Louis, MO) using the default Partek normalization parame-
ters. The robust multiarray average (RMA) normalization
method was used to normalize data. Statistically significant
differentially expressed genes between Akt1+/+ and Akt12/2
mammary glands were defined as having a p,0.05 as determined
by a one-way analysis of variance (ANOVA). The recovered P-
values of the statistically significant genes were corrected using a
step-up false discovery rate value of 5%. The final list of
differentially expressed genes included only those genes with a
1.5-fold change (up or down) with a p,0.05. Data was further
analyzed using Ingenuity Pathways Analysis (IPA) (IngenuityH
Systems, www.ingenuity.com). The IPA Functional Analysis
program was used to identify the biological functions and/or
diseases that were most significant to the data set. Only molecules
from the dataset meeting the p value cutoff of 0.05 and were
associated with biological functions and/or diseases in Ingenuity’s
Knowledge Base were considered for the analysis. Right-tailed
Fisher’s exact test was used to calculate a p-value determining the
probability that each biological function and/or disease assigned to
that data set was due to chance alone. IPA’s Pathway Analysis
generated graphical representation of the molecular relationships
between molecules, represented as nodes, and the biological
relationship between nodes, represented as an edge (line). All edges
were supported by at least 1 reference from the literature or from
canonical information stored in the Ingenuity Pathways Knowledge
Base. Nodes are displayed using various shapes that represent the
functional class of the gene product, while the intensity of the node
color indicates the degree of up- (red) or down- (green) regulation.
Edges are displayed with labels describing the nature of the
relationship between the nodes.
Quantitative RT-PCR
Total RNA (1 mg) was treated with DNase (Promega, Madison,
WI) and reverse-transcribed using the iScript cDNA Synthesis Kit
(Bio-Rad) according to the manufacturer’s protocols. cDNA
templates were amplified with pre-optimized mouse-specific
QuantiTectH primer assays (Qiagen, Valencia, CA) using iQ
SYBR Green Supermix (Bio-Rad) on an iCycler iQ Multicolor
Real-time PCR Detection System (Bio-Rad). Each 25 ml sample
was run in triplicate, and mRNA levels were analyzed relative to
hypoxanthine phosphoribosyltransferase (HPRT). Log2-trans-
formed relative expression ratios were calculated as described
using the equation set forth by Pfaffl (Pfaffl 2001).
Pseudopregnancy stimulation
Female mice at 60–90 days old were injected intraperitoneally
(i.p.) with 5.0 international units (IU) of PMSG (Sigma Aldrich)
followed by 5.0 IU of hCG i.p. 48 hours later. Mammary glands
were excised from mice 18 hours after hCG administration,
thoracic glands were flash frozen for RNA, and inguinal glands
were either processed for whole mounts or fixed in 10% neutral
buffered formalin.
Immunofluorescence
Indirect immunofluorescence was performed on formalin-fixed,
paraffin-embedded 7 mm sections. Sections were re-hydrated,
and antigen retrieval was performed by heating slides in 10 mM
sodium citrate in a steamer for 20 minutes. Sections were
blocked overnight with normal goat and rabbit serum (Vector
Laboratories, Burlingame, CA), and incubated with primary
antibodies against Btn1a1 (AV45164, Sigma-Aldrich) and Akt1
(sc-1618, Santa Cruz) followed by Alexa Fluor 488 rabbit
anti-goat (Invitrogen) and Alexa Fluor 594 goat anti-rabbit
(Invitrogen). Sections were counterstained with DAPI and
visualized on a microscope equipped with a digital camera and
software.
Cell culture and short-hairpin RNA knockdown
MCF-7 cells, a generous gift from the lab of Dr. Edward Filardo
(Brown University), were cultured in phenol red-free DMEM/F-
12 (Hyclone), 10% fetal bovine serum, 0.1% penicillin/strepto-
mycin in a humidified atmosphere (5% CO2/95%air). Retroviral-
mediated shRNA knockdown was performed as described in [23].
The oligonucleotides containing targeting sequences (shown in
uppercase) for firefly luciferase [short-hairpin luciferase (shLuc)]
controls, human Akt1 (shAkt1), and human Btn1a1 (shBtn1a1)
Akt1 in Mammary Development
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gagaCAATCAAGGCGTTGGTCGCtttttgga-39 for luciferase, 59-
gatccccGAGTTTGAGTACCTGAAGCttcaagagaGCTTCAGG-
TACTCAAACTCtttttggaaa-39 for Akt1, and 59-gatccccgcgt Gat-
agaggagagaatttcaagagaATTCTCTCCTCTATCACGCttttggaaa-39
for Btn1a1. Knockdown cells were maintained in 1.0 mg/ml
puromycin. For cell proliferation 100,000 cells were plated in each
well of a 6-well plate. Cell proliferation was determined by Trypan
blue exclusion using a TC-10 automated cell counter (Bio-Rad,
Hercules, CA), and calculating the percent change of in number of
cells relative to cell number on day 0.
Statistical analysis
A Bartlett test for homogeneity followed by a two-tailed students
t-test adjusted for equal variance were performed to test for
statistical significance. For genotype and exposure interactions, a
two-way ANOVA followed by a Tukey HSD test was performed.
A P value of ,0.05 was considered to be statistically significant.
Statistics were calculated using R software (R Project).
Results
Akt1 deficiency delays mammary gland postnatal
development
Previously identified roles for Akt1 in developmental delay and
reproductive impairment [11,14,17,19,20] led us to examine its
involvement in postnatal mammary gland development. We first
examined the growth patterns of mammary glands in Akt1+/+ and
Akt12/2 mice at different stages of postnatal development,
including neonatal (PND 11), juvenile (PND 25), pubertal (PND
50), and adult (PND 70) stages (Fig. 1 A–H). Akt12/2 mammary
glands exhibited significantly stunted ductal outgrowth during the
juvenile and pubertal time periods (PND 25 and PND 50,
respectively), but by adulthood (PND 70) the glands occupied the
same amount of space in the fat pad compared to Akt1+/+ mice
(Fig. 1 K). Accordingly, primary duct length was reduced in
Akt12/2 glands at both PND 11 and PND 25 (Fig. 1 I).
Analogous to the ductal outgrowth, at PND 50 growth past the
lymph node was shorter in Akt12/2 glands (Fig. 1 J). At
Figure 1. Akt1 promotes postnatal mammary gland growth. Representative whole mounts of Akt1+/+ (A–D) and Akt12/2 (E–H) mammary
glands at PND 11 (A,E), PND 25 (B,F), PND 50 (C,G), and PND 70 (D,H). Measurement of primary duct length at PND 11 and PND 25 in Akt1+/+ and
Akt12/2 glands (I). Measurement of the growth past the lymph node at PND 50 and PND 70 in Akt1+/+ and Akt12/2 glands (J). Quantification of
ductal outgrowth for Akt1+/+ and Akt12/2 mammary glands at PND 11, 25, 50, and 70 (K). Data represented in line plot as mean +/2 standard error.
Data represented in bar plots as mean + standard error. Scale bars indicate 1,000 mm. Statistical analyses were conducted using a two-tailed student’s
t test. **p,0.01, *p,0.05. n=3–8 per genotype, per age group.
doi:10.1371/journal.pone.0024432.g001
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Akt12/2 and Akt1+/+ glands (Fig. 1 J). Overall, these results
suggest that Akt1 is not necessary for the initial formation of the
rudimentary ductal tree during the neonatal period, but that it
does mediate ductal growth during puberty until adulthood when
Akt12/2 glands reach full outgrowth similar to their wild-type
counterparts.
Akt1 regulates the cell population in developing and
adult mammary glands
Considering the effects that Akt1 deficiency elicited on ductal
growth in the mammary gland, we next investigated the effects of
Akt1 loss on ductal branching and alveolar expansion in the
developing gland. Initial results indicated the Akt1 deficiency had
little effect on initial side branching at either PND 11 or PND 25
(Fig. S1). We evaluated terminal end bud bifurcation by
quantifying the number of terminal end buds, alveolar buds, and
terminal ducts in the Zone C area of the mammary gland
throughout development (Fig. 2, A–H) [22]. Akt1 deficiency
decreased the number of terminal end buds during the juvenile
time period (Fig. 2 I). The terminal end bud is characterized by
having an inner layer of body cells surrounded by an outer layer of
cap cells, which give rise to luminal cells and basal cells,
respectively [3]. This outer layer of cap cells is evident in the
Akt1+/+ mammary glands during puberty, but is near absent in
the Akt12/2 glands (Fig. 2 B, F). These terminal end buds are
normally present during puberty, and are permanently replaced
with alveolar buds and ducts when the mammary gland reaches
the end of the fat pad [7]. Therefore, calculating the percentage of
terminal end buds is useful for gauging the relative stage of
development of the mammary gland. Although Akt12/2 glands
contained a lower percentage of TEBs at PND25, there was a
trend for a higher percentage of TEBs during puberty (PND 50),
suggesting a more immature phenotype for the Akt12/2 glands at
puberty (Fig. 2 K).
Figure 2. Akt1 mediates the terminal end bud, terminal duct and alveolar bud population. Representative H&E images of Akt1+/+ (A–D)
and Akt12/2 (E–H) mammary glands at PND 11 (A,E), PND 25 (B,F), PND 50 (C,G), and PND 70 (D,H). Arrow indicates terminal end buds (B)
Quantification of terminal end buds in Akt1+/+ and Akt12/2 mammary glands at PND 11, 25, 50 and 70 (I). Quantification of total buds and terminal
ducts in Akt1+/+ and Akt12/2 mammary glands at PND 11, 25, 50 and 70 (J). Quantification of the terminal end buds relative to the total number of
buds of Akt1+/+ and Akt12/2 mammary glands at PND 11, 25, 50 and 70 (K). Scale bars indicate 100 mm. Data represented in line plots as mean +/2
standard error. Statistical analyses were conducted using a two-tailed student’s t test. **p,0.01, *p,0.05, #p,0.1. n=3–8 per genotype, per age
group.
doi:10.1371/journal.pone.0024432.g002
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and ducts during puberty (PND 50), which persisted into
adulthood (PND 70) (Fig. 2 J). While Akt12/2 glands eventually
reach the same size as their wild-type counterparts, the overall
alveolar bud and terminal duct population remains lower,
indicating a permanent change in mammary gland structure.
This alveolar bud deficiency could be attributed to the earlier lack
of terminal end buds, which contain the progenitor cells for
alveolar and ductal myoepithelial and epithelial cells. Importantly,
this apparent lack of alveolar buds and ducts may be a potential
reason for abnormal mammary gland reconstruction during
pregnancy and lactation in Akt12/2 glands as seen in other
studies [14].
Akt1 influences mRNA patterns in the adult mammary
gland
The deficiency in alveolar buds and terminal ducts in Akt12/2
adult mammary glands led us to examine the effects of Akt1
deficiency on gene expression in the adult mammary gland. We
performed Affymetrix gene arrays on PND 70 Akt1+/+ and
Akt12/2 thoracic mammary glands, which indicated differential
expression of 119 genes with a fold change of ,1.5 and a p-value
of ,0.05 (Table S1). Real-time RT-PCR validation of selected
genes from the gene array indicated strong correlation between
gene array results and RT-PCR. The genes chosen for validation
were butyrophilin, subfamily 1, member A1 (Btn1a1), v-akt murine thymoma
viral oncogene homolog 1 (Akt1), myotubularin related protein 7 (Mtmr7),
Figure 3. Akt1 influences gene expression patterns in the adult mammary gland. Microarray results were validated with qRT-PCR for the
genes Btn1a, Akt1, Mtmr7, Muc1, Lbh, Dsc3, Pou2af, and Faim3. Data represented as fold change in gene expression for Akt12/2 vs. Akt1+/+ (A). IPA
analysis generated the top ten biological functions and diseases altered by the loss of Akt1 (B) IPA analysis generated an association network
connecting cardiovascular system development and function, organismal development, and cancer (C). Statistical analyses for qRT-PCR were
conducted using a two-tailed student’s t test. **p,0.01, *p,0.05, #p,0.1. n=3 per genotype for microarray, n=6 per genotype for qRT-PCR.
doi:10.1371/journal.pone.0024432.g003
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3 (Dsc3), POU class 2 associating factor 1 (Pou2af), and fas apoptotic
inhibitory molecule 3 (Faim3) (Fig. 3 A). We also validated the absence
of Akt1 protein in the adult mammary glands by western blot, as
well as the presence of Akt isoforms Akt2 and Akt3 (Fig. 4).
Ingenuity pathway analysis indicated several altered biological
functions as a result of Akt1 ablation, including cell-to-cell
signaling, intercellular interaction, tissue morphology, organismal
development, and cancer within the top ten altered functions
(Fig. 3 B). Pathway analysis further illustrated that the pattern of
differential gene expression was highly associated with cardiovas-
cular system development and function, organismal development,
and carcinogenesis pathways (Fig. 3 C).
Alveolar cell death incidence and alveolar bud diameter
are dependent on Akt1
Our previous results indicated that Akt1 is necessary to maintain
proper alveolar bud population in adulthood. Given the pro-
survival role of Akt1 during pregnancy and lactation [14,19] and
the ability of Akt1 to block several pro-apoptotic processes, we
examined the effect of Akt12/2 loss on localization of fibrin and
collagen in the mammary gland, alveolar bud size, and mammary
epithelial cell death. Collagen and fibrin deposition were not
altered by the ablation of Akt1, indicating normal stromal
architecture in Akt1+/+ and Akt12/2 mammary glands (Fig. 5
A, C). However, there was a strong trend for decreased alveolar
bud diameter in Akt12/2 mammary glands, concomitant with
increased epithelial cell apoptosis (Fig. 5 B, D–F). Considering that
our gene array results denoted cell death and tissue morphology to
be two of the top ten altered biological processes altered by Akt1
deficiency, these data further suggest that apoptosis and alveolar
bud formation in the mammary gland are dependent, in part, on
Akt1.
Akt1 affects mammary gland lobuloalveolar development
and Btn1a1 expression during psuedopregnancy
Prior studies have indicated that Akt1 is necessary for proper
lobuloalveologenesis and lactation during pregnancy and nursing.
We chose to study the role of Akt1 in alveolar differentiation during
pseudopregnancy based on our findings of its effects on mammary
gland development during puberty and on subfertility in Akt12/2
females. Similar to previous work using naturally pregnant mice,
Akt1 affects the frequency of formation of lobuloalveolar structures
in pseudopregnant mice (Fig. 6 A–D). While Akt1 deficiency
reduces the number of differentiated alveolar buds, it is not
required for alveolar differentiation, as indicated by the presence
of alveoli (Fig. 6 D). This is in contrast to previous work that
concluded that ablation of Akt1 inhibits the formation of
lobuloalveolar structures, but this is likely due to the fact that
our study induced pseudopregnancy, whereas prior work utilized
naturally pregnant animals [14]. Considering the decreased
number of alveolar buds and ducts in adult virgin Akt12/2
mammary glands, our results indicate that Akt1 is necessary for the
initial formation of alveolar buds during development and relative
number of lobuloalveolar structures formed during pregnancy, but
is not necessary for alveologenesis.
Our gene array and real-time RT-PCR results indicated that
the loss of Akt1 in the mammary gland significantly decreased
expression of Btn1a1, a member of the butyrophilin Ig superfamily
that is basally expressed in the brain, heart, lymph node, ovary and
uterus, thymus, lung, spleen, and mammary gland [24]. Bnt1a1
is highly expressed in the secretory epithelium of lactating
mammary glands, and is essential for milk lipid secretion [21].
Btn1a1 and Akt1 were co-expressed in pseudopregnant mammary
glands (Fig. 6 E, G, I), and expression of Btn1a1 was decreased in
Akt12/2 glands, signifying that Akt1 is necessary for proper
protein expression of Btn1a1 in the mammary gland (Fig. 6 H).
Additionally, while Akt1+/+ mammary glands responded to
pseudopregnancy by significantly increasing the levels of Btn1a1
as compared to virgin glands, Akt12/2 mammary glands failed to
do so (Fig. 6 K). Btn1a1 expression in Akt12/2 glands during
pseudopregnancy was also significantly decreased as compared to
pseuodpregnant Akt1+/+ glands. A two-way ANOVA analysis
revealed that both Akt1 genotype status and exposure (pseudo-
pregnancy) were significant factors in determining Btn1a1
expression.
Akt1 promotes cell proliferation and Btn1a1 and ß-casein
gene expression in MCF7 human breast epithelial cells
In order to directly address whether Btn1a1 or ß-casein are
downstream of Akt1, we evaluated the effect of shRNA-mediated
knockdown of Akt1 or Btn1a1 in MCF7 human breast epithelial
cells on ß-casein, a gene that encodes for a milk protein expressed
during early lactational mammary epithelial differentiation [11].
MCF7 cells expressing shRNA targeting Akt1 (shAkt1) exhibited
significant decreases in cell proliferation after 4–6 days of growth
in culture (Fig. 7 A). Knockdown of Akt1 also resulted in
significant decreases in both Btn1a1 and ß-casein expression (Fig. 7
B), while knockdown of Btn1a1 (shBTN1A1) decreased expression
of Btn1a1 and ß-casein, but not Akt1 (Fig. 7 B, Fig. S2.).
Discussion
The mammary gland is a critical reproductive organ, and the
abilities of the adult mammary gland to undergo normal
development and proper lobuloalveolar remodeling during
pregnancy are critical for reproductive health. The mammary
gland is distinct from other organs because it undergoes most of its
branching postnatally with the onset of puberty rather than in utero.
Proper branching morphogenesis is fundamental for functional
development and differentiation to occur in adulthood. Using an
Akt1+/+ and Akt12/2 mouse model to examine postnatal
development in vivo, we found that Akt1 is essential for proper
mammary gland organogenesis and appropriate adult mammary
homeostasis. Mammary gland development can be separated into
three distinct stages: embryonic, adolescent, and adult. We found
that the initial branching and formation of the rudimentary duct
occurred normally in Akt12/2 mammary glands, indicating that
Figure 4. Western blot analysis of Akt isoform expression in
PND 70 Akt1+/+ and Akt1/2 mammary glands. Western blots of
Akt1 (A), Akt2 (B), Akt3 (C), and GAPDH (D) in PND 70 Akt1+/+ and
Akt12/2 mammary glands are representative of 5–8 animals per
genotype.
doi:10.1371/journal.pone.0024432.g004
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These results are not surprising considering embryonic mammary
development is also hormone-independent, and PI3K/AKT
activates ERa [25].
We did find that postnatal mammary gland development is
Akt1-dependent. Unlike embryonic growth, postnatal development
requires estrogen and progesterone, which are secreted by the
ovaries at approximately three weeks of age in the mouse. Ductal
outgrowth of inguinal mammary glands was significantly reduced
in Akt12/2 glands during early and late pubertal time points.
However, by adulthood these glands occupied the same amount of
space in the fat pad as their wild-type counterparts. Our previous
work indicated that Akt12/2 female mice had higher levels of
estradiol and lower levels of progesterone than Akt1+/+ females
during late puberty, but that these levels were similar in both
genotypes by adulthood irrespective of Akt1 status [20]. Consid-
ering that postnatal ductal growth and alveolar expansion are
dependent on estradiol and progesterone, the higher levels of
progesterone most likely have a compensatory effect on ductal
outgrowth, allowing for the Akt12/2 mammary glands to reach
full size. Conversely, the levels of estradiol may be a contributing
factor to the altered terminal end bud and alveolar expansion seen
in the Akt12/2 glands. Mammary gland postnatal ductal
development is driven by the rapid growth of the terminal end
bud, a unique structure that contains dichotomously dividing stem
cells during puberty. The terminal end bud contains a ‘tube within
a tube’ structure, with an outer layer of undifferentiated cap cells
and an inner layer of luminal epithelial cells. Both layers have high
rates of mitosis, and normally have rates of forward growth
through the fat pad of about 0.5 mm per day [26]. Akt1 deficiency
resulted in a significant decrease in the terminal end bud
population during puberty, and a significant decrease in total
alveolar buds and a strong trend for decreased alveolar bud size in
adulthood. We also demonstrated that suppression of Akt1 in
human breast epithelial cells inhibited cell proliferation, further
illustrating the importance of Akt1 in mammary epithelial cell
growth. The growth of the terminal end bud relies both on
estradiol and growth factors elicited by the stroma, such as insulin-
like growth factor-1 (IGF-1). Notably, the AKT pathway has been
implicated in both estrogen and insulin signaling [9,25].
Moreover, Akt has been shown to be phosphorylated downstream
of IGF-1 [27]. In our model, Akt1 could be a potential mediator of
IGF-1 and estrogen signaling to the terminal end bud, and its
deficiency results in a lack of bifurcation.
The permanent structural changes in Akt12/2 mammary
glands led us to examine alterations in gene expression in adult
glands. We chose to validate a set of genes based on their high
rates of fold change and relative importance in growth and
differentiation processes. For example, Akt12/2 glands exhibited
increased expression of Lbh, a gene normally expressed during
development in branched limbs and the heart, which could be a
compensatory mechanism for the observed deficiency in postnatal
growth and bud development. Over-expression and deregulation
of Lbh results in suppression of epithelial cell differentiation and a
potential involvement in Wnt-induced breast tumorigenesis [28].
Our findings further suggest that the lack of Akt1 in the mammary
gland may also disrupt its functional role in lactation. Akt1 has
previously been found to be involved in the proper formation of
lobuloalveolar units during pregnancy, as well as in proper milk
production during nursing. The phenotype of Akt12/2 mamma-
ry glands has been described, including the inhibition of
lobuloalveolar units and survival in mammary epithelia during
pregnancy [14].
We chose to investigate the molecular basis of abnormal
mammary gland function based on our prior results indicating
decreased expression of Btn1a1 in Akt12/2 mammary glands.
Btn1a1 has recently been found to be a crucial gene for proper milk
lipid secretion during lactation. We induced pseuodopregnacy to
Figure 5. Akt1 influences alveolar bud diameter and apoptosis incidence in adult mammary glands. Martius yellow, soluble blue,
brilliant crystal (MSB) stain of Akt1+/+ (A) and Akt12/2 (C) PND 70 mammary glands. Blue staining indicates collagen and purple staining indicates
fibrin. TUNEL staining in Akt1+/+ (B) and Akt12/2 (D) PND 70 mammary glands. Measurement of alveolar bud diameter in Akt1+/+ and Akt12/2 PND
70 mammary glands (E). Measurement of TUNEL positivity in Akt1+/+ and Akt12/2 PND 70 mammary glands (F). Arrow indicates apoptotic cells in
the Akt12/2 gland. Scale bars indicate 100 mm. Data represented as mean plus standard error. Statistical analyses were conducted using a two-tailed
student’s t test. #p=0.08, *p,0.05. n=4 per genotype for (E), n=3 per genotype for (F).
doi:10.1371/journal.pone.0024432.g005
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pseudopregnant Akt1+/+ (A) and Akt12/2 (B) mammary glands, and H&E stained (C, D) mammary glands. Representative immunofluorescence of
Akt1 and Btn1a1 in pseudopregnant Akt1+/+ (E, G, I) and Akt12/2 (F, H, J) mammary glands. Arrow indicates co-expression of Akt1 and Btn1a1 the in
Akt1+/+ mammary gland epithelium. Btn1a1 gene expression as determined by real time RT-PCR in virgin and pseuodopregnant Akt1+/+ and Akt12/2
thoracic mammary glands (K). Exposure=pseudopregnancy. Scale bars for whole mounts and histology/immunohistochemistry indicate 1,000 mm and
100 mm, respectively. Data represented as mean plus standard error. Statistical analyses were conducted by a two-way ANOVA followed by a Tukey HSD
test. **p,0.01 for Tukey HSD post-hoc test. n=3–6 per genotype, per exposure.
doi:10.1371/journal.pone.0024432.g006
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PMSG and hCG injections in Akt1+/+ and Akt12/2 adult
females since Akt12/2 females have high rates of fetal resorptions
and are subfertile [20]. Following hormonal stimulation, Akt1+/+
mammary glands exhibited increased expression of Btn1a1,
suggesting that Btn1a1 induction occurs normally during pregnan-
cy, likely in preparation for milk production during nursing, as
Btn1a1 is required for the secretion of milk lipid droplets [24].
Akt12/2 mammary glands failed to induce an increase in
expression of Btn1a1 during pseudopregnancy compared to a
virgin state, and had significantly decreased Btn1a1 expression
compared to pseuodopregnant Akt1+/+ glands. Furthermore,
knockdown of Akt1 in human breast epithelial cell decreased
expression of ß-casein, Btn1a1 and Akt1, and knockdown of Btn1a1
decreased expression of ß-casein and Btn1a1, but not Akt1. These
data suggest that Btn1a1 is downstream of Akt1, and ß-casein is
further downstream. These data, taken together with the
previously shown roles of Btn1a1 and Akt1 in lactation, suggest a
regulation of Btn1a1 by Akt1 in the mammary gland, and that Akt1
may promote milk protein production through Btn1a1 and
subsequent ß-casein expression. Collectively, while Akt12/2
mammary glands can form alveoli during pseudopregnancy, they
are fewer in number and potentially dysfunctional in their milk
production.
IPA revealed that several genes involved in organismal
development, cell death, tissue morphology, and cancer were
altered Akt12/2 mammary glands. The roles of the PI3K/AKT
pathway in cell survival and apoptosis have been extensively
studied, but we found differential expression of additional genes
that may be involved in this process, including Mtmr7, Pou2af, and
Faim3, which play roles in either cell survival or apoptosis. We also
found that Akt1 deficiency resulted in decreased alveolar bud
diameter and increased epithelial cell apoptosis, which could
decrease the quantity of alveolar buds and terminal ducts in adult
Akt12/2 glands. However, cell growth in terminal end buds and
alveolar buds not only relies on mitogenic signals for proliferation,
but also on cell-cell contacts for forward growth. Cell-cell signaling
and interaction was another biological process altered by Akt1
deficiency, which included several altered genes such as Dsc3,a
member of the cadherin superfamily. Cadherins are calcium-
Figure 7. Akt1 is required for epithelial cell proliferation and Btn1a1 and ß-casein gene expression. Percent change in cell growth over 6
days in MCF7 cells expressing shAkt1 or shLuciferase control (A). Relative gene expression of Akt1, Btn1a1, and ß-casein in shAkt1, shBtn1a1, or
shLuciferase cells (B). Data represented as mean plus standard error. Statistical analyses were conducted using two-tailed student’s t tests. #p,0.1,
**p,0.01, *p,0.05 compared to shLuciferase control. n=3 independent infections.
doi:10.1371/journal.pone.0024432.g007
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and several cadherins are expressed in mammary gland alveolar
buds and terminal end buds. Previous research has indicated that
disruption of cell-cell contacts inhibits forward growth, suggesting
that these interactions are essential for proper mammary gland
growth through the fat pad [26]. It is possible that aberrant
signaling in the absence of Akt1 disrupted cell-cell signaling,
resulting in improper growth, as demonstrated in the delayed
ductal outgrowth and deficiency in terminal end bud growth and
alveolar bud development. Collectively, our findings suggest that
Akt signaling is essential for proper alveolar bud apoptosis,
quantity, growth, and size.
Considering prior studies and our novel findings, it is likely that
Akt1 is necessary for both proper mammary gland postnatal
growth and functional adult development. Regarding postnatal
growth, Akt1 appears essential for ductal outgrowth through the fat
pad as well as for the bifurcation of terminal end buds and
formation of alveolar buds and terminal ducts. Permanent changes
in mammary gland composition and gene expression are likely
contributing factors to the abnormal function of adult Akt12/2
mammary glands. Regarding Btn1a1, it seems that Akt1 is essential
for its expression both during a basal virgin state as well as during
pseudopregnancy. The lack of Btn1a1 and Akt1 expression, both of
which influence milk lipid production, can result in increased
offspring mortality, suggesting these genes are essential for proper
reproductive health and offspring growth.
Supporting Information
Figure S1 Akt1 does not mediate initial side branching
in the developing mammary gland. Quantification of the
number of branch points in the mammary gland at PND 11 and
PND 25. Data represented as mean plus standard deviation.
Statistical analyses were conducted using a two-tailed student’s t
test. n=3–8 per genotype, per age group.
(TIF)
Figure S2 Selective knockdown of the Akt1 isoform in
MCF7 human mammary epithelial cells. Western blot
analysis of Akt1, Akt2, Akt3, and GAPDH in MCF7 cells
expressing shLuciferase, shBtn1a1 or shAkt1.
(TIF)
Table S1 Differentially expressed gene list in Akt12/2
mammary glands. Listed are the statistically significant genes
with a p,0.05 and a fold-change of ,1.5 in adult Akt12/2
mammary glands compared to Akt1+/+ mammary glands.
(DOC)
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